| Literature DB >> 22950025 |
Tina Wecke, Petra Halang, Anna Staroń, Yann S Dufour, Timothy J Donohue, Thorsten Mascher.
Abstract
Bacteria need signal transducing systems to respond to environmental changes. Next to one- and two-component systems, alternative σ factors of the extra-cytoplasmic function (ECF) protein family represent the third fundamental mechanism of bacterial signal transduction. A comprehensive classification of these proteins identified more than 40 phylogenetically distinct groups, most of which are not experimentally investigated. Here, we present the characterization of such a group with unique features, termed ECF41. Among analyzed bacterial genomes, ECF41 σ factors are widely distributed with about 400 proteins from 10 different phyla. They lack obvious anti-σ factors that typically control activity of other ECF σ factors, but their structural genes are often predicted to be cotranscribed with carboxymuconolactone decarboxylases, oxidoreductases, or epimerases based on genomic context conservation. We demonstrate for Bacillus licheniformis and Rhodobacter sphaeroides that the corresponding genes are preceded by a highly conserved promoter motif and are the only detectable targets of ECF41-dependent gene regulation. In contrast to other ECF σ factors, proteins of group ECF41 contain a large C-terminal extension, which is crucial for σ factor activity. Our data demonstrate that ECF41 σ factors are regulated by a novel mechanism based on the presence of a fused regulatory domain.Entities:
Keywords: Anti-σ factor; ECF σ factor; signal transduction
Year: 2012 PMID: 22950025 PMCID: PMC3426412 DOI: 10.1002/mbo3.22
Source DB: PubMed Journal: Microbiologyopen ISSN: 2045-8827 Impact factor: 3.139
Bacterial strains used in this study
| Strain | Genotype or characteristic(s) | Source orreference |
|---|---|---|
| S17–1 | C600::RP-4 2-(Tc::Mu)(Km::Tn | |
| DH5α | ||
| W168 | Wild-type strain, | Laboratory stock |
| 1A774 | JH642 | BGSC (C. Moran) |
| TMB1099 | 1A774 pPH0401 | This study |
| TMB1100 | 1A774 pPH0403 | This study |
| TMB1101 | 1A774 pTW0412 | This study |
| TMB695 | W168 pPH0401 | This study |
| TMB746 | W168 pPH0403 | This study |
| TMB666 | W168 pTW0412 | This study |
| TMB428 | W168 | This study |
| TMB455 | TMB428 | This study |
| TMB451 | W168 | This study |
| TMB456 | TMB428 | This study |
| TMB858 | W168 | This study |
| TMB574 | TMB451 | This study |
| TMB575 | TMB451 | This study |
| TMB577 | TMB451 | This study |
| TMB896 | TMB858 | This study |
| TMB897 | TMB858 | This study |
| TMB899 | TMB858 | This study |
| TMB623 | TMB428 pHCMC04 | This study |
| TMB696 | TMB428 pPH0401 | This study |
| TMB742 | TMB428 pPH0403 | This study |
| TMB741 | TMB428 pPH0402 | This study |
| TMB667 | TMB428 pTW0412 | This study |
| DSM13 | Wild-type strain | Laboratory stock |
| MW3 | DSM13Δ | |
| TMBli003 | MW3 Δ | This study |
| TMBli006 | MW3 Δ | This study |
| 2.4.1 | Wild-type strain | Laboratory stock |
| TMR003 | 2.4.1 pTW0503 | This study |
| TMR005 | YSD418 pTW0501 | This study |
| TMR006 | YSD418 pTW0502 | This study |
| TMR007 | YSD418 pTW0503 | This study |
| YSD418 | 2.4.1 PRSP_0606::pSUP202- | This study |
| YSD354 | 2.4.1 pIND4 | This study |
| YSD239 | 2.4.1 ΔRSP_0606- | This study |
| YSD331 | YSD239 pIND4 | This study |
| YSD333 | 2.4.1 pYSD161 | This study |
| YSD434 | YSD418 pIND4 | This study |
Vectors and plasmids used in this study
| Name | Genotype or characteristic features | Primers for cloning | Source or reference |
|---|---|---|---|
| Vectors | |||
| pDG1663 | |||
| pHCMC04 | Xylose-inducible expression vector, CmR | ||
| pIND4 | IPTG-inducible expression vector, KnR | ||
| pSUP202 | Mobilizable vector, ApR, CmR, TcR | ||
| pSWEET | Xylose-inducible expression vector, integrates in | ||
| pMAD | Shuttle vector for construction of makerless deletion mutans, MLSR | ||
| pHP45Ω | Source of Ω::SpecR cassette | ||
| pGEM-T | Cloning vector | Promega Corp. | |
| Plasmids | |||
| pTW101 | pMAD | 779/780, 781/782 | This study |
| pTW102 | pMAD | 783/784, 785/786 | This study |
| pTW6302 | pDG1663 P | 712/713 | This study |
| pTW6304 | pDG1663 P | 1130/1131 | This study |
| pTW6305 | pDG1663 P | 1136/1137 | This study |
| pTW6307 | pDG1663 P | 1132/1133 | This study |
| pTW901 | pSWEET | 699/669 | This study |
| pTW902 | pSWEET | 699/705 | This study |
| pPH901 | pSWEET | 699/1576 | This study |
| pPH0401 | pHCMC04 | 1416/1294 | This study |
| pPH0403 | pHCMC04 | 1416/1469 | This study |
| pPH0402 | pHCMC04 | 1416/1468 | This study |
| pTW0412 | pHCMC04 | 1416/1411 | This study |
| pSUP202- | pSUP202 with promoter-less | 199/200 | This study |
| pSUP202-PRSP_0606- | PRSP_0606 fused to | 109/219 | This study |
| pYSD122 | pSUP202 with the Ω::SpecR cassette and genomic regions flanking RSP_0606- | 109/110/125/126 | This study |
| pYSD161 | pIND4 | 185/186 | This study |
| pTW0501 | pIND4 | 1881/1603 | This study |
| pTW0502 | pIND4 | 1881/1604 | This study |
| pTW0503 | pIND4 | 1881/1605 | This study |
Resistance cassettes: MLSR, macrolide-lincosamide-streptogram; CmR, chloramphenicol; KnR, kanamycin; ApR, ampicillin; TcR, tetracycline; SpecR, spectinomycin.
Phylogenetic distribution of ECF41 σ factors
| Phyla | ECF41 proteins per phylum | Percentage of ECF41 proteins | Species with ECF41 protein | Percentage of sequenced species | Sequenced genomes/species |
|---|---|---|---|---|---|
| Actinobacteria | 252 | 68 | 60 | 51 | 181/118 |
| Proteobacteria | 84 | 23 | 66 | 15 | 705/414 |
| Firmicutes | 15 | 4.0 | 10 | 2.5 | 404/182 |
| Chloroflexi | 11 | 2.9 | 3 | 60 | 15/5 |
| Acidobacteria | 4 | 1.1 | 4 | 67 | 6/6 |
| Bacteriodetes | 2 | 0.5 | 2 | 4.4 | 53/45 |
| Cyanobacteria | 2 | 0.5 | 2 | 6.3 | 44/32 |
| Spirochaetes | 1 | 0.3 | 1 | 5.6 | 23/18 |
| Verrucomicrobia | 1 | 0.3 | 1 | 25 | 4/4 |
| Gemmatimonadetes | 1 | 0.3 | 1 | 100 | 1/1 |
Numbers of sequenced genomes and species of each phylum were extracted from the MiST2 database (Ulrich and Zhulin 2010) in October 2010.
Figure 1Phylogenetic tree of ECF41 σ factors. The phylogenetic tree is based on a gapless multiple sequence alignment of 373 ECF41 protein sequences constructed using ClustalW (Thompson et al. 1994). The resulting phylogenetic tree was calculated using the neighbor-joining method of the Phylip (Felsenstein 1989) program Protdist implemented in the BioEdit Sequence Alignment Editor (Hall 1999). Assignment to bacterial phyla is indicated by a color code. Ecf41Rsp of Rhodobacter sphaeroides, Ecf41Bli of Bacillus licheniformis, and σJ of Mycobacterium tuberculosis are highlighted.
Figure 2Genomic context conservation of ECF41 σ factors. ECF σ factors are shown by black, carboxymuconolactone decarboxylases by gray, oxidoreductases by striped and epimerases by dotted arrows. Genes encoding hypothetical proteins, that either contain the conserved ECF41-dependent promoter motif (Fig. 4) or are located between the ECF41 σ factor and the COE, are displayed in white. The genomic context is represented according to the phylum with the number of species in parentheses. The number in front of each context indicates how often this combination of genes occurs within the designated phylum.
Genomic context and promoter occurrence
| Genomic context | Number | PECF | PCOE |
|---|---|---|---|
| >ECF> | 126 (34%) | 38 | n.a. |
| >COE> >ECF> | 107 (29%) | – | 97 |
| >ECF> >COE> | 53 (14%) | 14 | 24 |
| >ECF> <COE< | 9 (2%) | 3 | 4 |
| <ECF< >COE> | 55 (15%) | 36 | 41 |
| Ungrouped | 23 (6%) | n.a. | n.a. |
The arrows indicate the organization of the genes. ECF, gene encoding an ECF41 σ factor; COE, gene encoding a carboxymuconolactone decarboxylase, oxidoreductase, or epimerase; ungrouped, genomic context differs from the above-mentioned groups and contains genes encoding hypothetical proteins of unknown function.
“-”, no promoter occurs upstream of the gene; n.a., the corresponding gene is not present or was omitted from analysis in case of ungrouped genomic context.
Figure 4Targets of ECF41-dependent signal transduction. (A) Genomic context organization and target promoter sequence of the ECF41 σ factors from B. licheniformis and R. sphaeroides. Genes encoding the ECF41 σ factor (black) and the carboxymuconolactone decarboxylase (gray) as well as the promoter sequences are shown. Flanking genes not belonging to the ECF41 loci are shown in white. The –35 and –10 region, the transcriptional start site +1, and the ATG start codon are highlighted in bold. The RACE adapter sequence is indicated by lower case letters. (B) Northern Blot analysis of Ecf41Bli-dependent ydfG expression in B. licheniformis. Bacillus licheniformis MW3 (wt) and TMBli003 (Δecf41Bli) were grown aerobically in LB medium. At the time points indicated by arrows, samples of both strains were harvested and total RNA was prepared. A total of 10 μg total RNA was separated on a 1% formaldehyde gel and transferred to a nylon membrane followed by hybridization and detection with a DIG-labeled ydfG-specific probe. Ribosomal RNA is shown to ensure equal amounts of RNA in each lane. (C) Weblogo of ECF41-dependent target promoters. The weblogo was generated using the WebLogo tool (Crooks et al. 2004) available at http://weblogo.berkeley.edu. The weblogo graphically represents a position weight matrix and illustrates the degree of sequence conservation for each nucleotide. The matrix is based on 285 putative promoter sequences identified upstream of genes encoding ECF41 σ factors and COEs. (D) ECF41-dependent target promoter activation. Bacillus subtilis strains TMB696 (Ecf41Bli) and TMB623 (pHCMC04) were grown in LB medium to OD600 ∼0.4 and split into two samples. In one sample, expression of Ecf41Bli was induced by addition of 0.5% xylose and cells were harvested after 1 h. Rhodobacter sphaeroides strains TMR005 (Ecf41Rsp) and YSD434 (pIND4) were grown in Sistrom's minimal medium to OD600 ∼0.3 and split into two samples. In one sample, expression of Ecf41Rsp was induced by 100 μM IPTG. After 3 h, the cells were harvested. P and PRSP_0606 activities were measured by β-galactosidase assays with normalization to cell density.
Figure 3Characteristic features of group ECF41 proteins and comparison with classical ECF σ factors. The multiple sequence alignment of selected ECF σ factors was constructed using ClustalW (Thompson et al. 1994). Identical amino acids at the same position are shaded in black, similar amino acids in gray. The σ2 and σ4 domains and the C-terminal extension are marked. Conserved motives of ECF41 proteins are defined by the complete multiple sequence alignment of group ECF41 (Fig. S1) and are highlighted. Abbreviations: Bce, Bacillus cereus; Bli, B. licheniformis; Bsu, B. subtilis; Eco, Escherichia coli; Nfa, Nocardia farcinica; Rsp, Rhodobacter sphaeroides; Reu, Ralstonia eutropha.
Putative ECF41 target promoters in B. licheniformis and R. sphaeroides
| Gene | Promoter sequence2 | 5′UTR3 | Putative function, homology |
|---|---|---|---|
| BLi01248 | 142 | Hypothetical, putative membrane protein | |
| Bli03073 | 109 | Hypothetical, putative membrane protein | |
| 163 | Putative phosphatase | ||
| 76 | Transcription attenuation protein | ||
| 199 | Stress response protein | ||
| 39 | Purine catabolism regulatory protein | ||
| 97 | Sulfate adenylyltransferase, dissimilatory-type | ||
| 60 | Stage II sporulation protein SB | ||
| 120 | DNA-damage repair protein | ||
| 68 | Firmicutes ribosomal L7Ae family protein | ||
| 31 | Putative carboxymuconolactone decarboxylase | ||
| 42 | Heme ABC type transporter HtsABC, permease | ||
| 108 | ABC transporter, ATP-binding protein | ||
| 48 | Unknown, LysM domain, cell wall degradation | ||
| 63 | Maltose/maltodextrin ABC transporter | ||
| 151 | Glycine cleavage system H protein, | ||
| 152 | RepA partitioning protein/ATPase, ParA type | ||
| 20 | Ribosomal protein | ||
| 32 | Putative carboxymuconolactone decarboxylase | ||
Genes highlighted in bold were tested for activation by the corresponding ECF41 σ factor.2Underlining indicates –35 (left) and –10 (right) regions, the spacing was adjusted indicated by dashes.35′UTR, length of 5′-untranslated region (in nucleotides) between the postulated transcriptional start site and the AUG start codon.
Figure 5Effect of C-terminal truncations of ECF41 σ factors on target promoter activation. (A) Schematic representation of C-terminally truncated Ecf41Bli proteins of B. licheniformis. The name of each variant is given at the beginning of each line and correlates with the length of the protein. The domains σ2 and σ4 as well as the C-terminal extension are displayed as gray boxes. The amino acid sequence of the highly conserved motives is shown. (B) β-galactosidase activities of B. subtilis strains overexpressing truncated Ecf41Bli-FLAG proteins. Strains TMB696 (wt), TMB742 (204), TMB741 (192), and TMB667 (167) were grown in LB medium to OD600 ∼0.4 and split into two samples. In one sample, protein expression was induced by addition of 0.5% xylose. The cells were harvested after 1 h and β-galactosidase activity was measured. Expression of the Ecf41Bli variants was verified by Western Blot using a FLAG-tag-specific antibody and is shown below. (C) Schematic representation of C-terminally truncated Ecf41Rsp proteins of R. sphaeroides. Details are shown as described for Figure 4. (D) β-galactosidase activities of R. sphaeroides strains overexpressing truncated Ecf41Rsp proteins. Strains TMR005 (wt), TMR006 (169), and TMR007 (206) were grown in Sistrom's minimal medium to OD600 ∼0.4 and split into two samples. In one sample, expression of Ecf41Rsp variants was induced by 100 μM IPTG. After 3 h, the cells were harvested and β-galactosidase assays were performed.
Figure 6Interaction of Ecf41Bli with RNA polymerase. (A) SDS-PAGE of Ni affinity-purified proteins from strains TMB1099 (wt), TMB1100 (204), and TMB1101 (167) carrying a His6-tag fused to the β′ subunit of the RNAP. The different truncated versions of Ecf41Bli-FLAG were overexpressed and the RNAP complex was purified (see Materials and Methods for details). A total of 5 μg of the cleared lysate and 5 and 10 μg of the 100 mM imidazole elution fraction were loaded. (B) Detection of copurified Ecf41Bli-FLAG and its variants by Western Blot analysis of a gel identical to the one in (A) using a FLAG-tag-specific antibody.